These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 36378949

  • 1. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
    Gentle SJ, Travers CP, Clark M, Carlo WA, Ambalavanan N.
    Am J Respir Crit Care Med; 2023 Apr 01; 207(7):921-928. PubMed ID: 36378949
    [Abstract] [Full Text] [Related]

  • 2. Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.
    Nawaytou H, Hills NK, Clyman RI.
    Pediatr Res; 2023 Aug 01; 94(2):547-554. PubMed ID: 36804505
    [Abstract] [Full Text] [Related]

  • 3. Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
    Villamor E, van Westering-Kroon E, Gonzalez-Luis GE, Bartoš F, Abman SH, Huizing MJ.
    JAMA Netw Open; 2023 Nov 01; 6(11):e2345299. PubMed ID: 38015504
    [Abstract] [Full Text] [Related]

  • 4. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
    Deng Y, Zhang H, Zhao Z, Du J, Bai R, McNamara PJ.
    Eur J Pediatr; 2022 Aug 01; 181(8):3131-3140. PubMed ID: 35838780
    [Abstract] [Full Text] [Related]

  • 5. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants].
    Chen C, Huang P, Lin BC, Chen XY, Zhao J, Sun HY, Yu YL, Chen S, Qiu XM, Yang CZ.
    Zhonghua Er Ke Za Zhi; 2020 Sep 02; 58(9):747-752. PubMed ID: 32872715
    [Abstract] [Full Text] [Related]

  • 6. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
    Fritz AS, Keller T, Kribs A, Hünseler C.
    Eur J Pediatr; 2023 Jul 02; 182(7):3075-3082. PubMed ID: 37072630
    [Abstract] [Full Text] [Related]

  • 7. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S, Dobryanskyy D, Sekretar L.
    BMC Pediatr; 2021 Jun 19; 21(1):286. PubMed ID: 34147090
    [Abstract] [Full Text] [Related]

  • 8. Patent Ductus Arteriosus and Lung Magnetic Resonance Imaging Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.
    Bjorkman KR, Miles KG, Bellew LE, Schneider KA, Magness SM, Higano NS, Ollberding NJ, Hoyos Cordon X, Hirsch RM, Hysinger E, Woods JC, Critser PJ.
    Am J Respir Crit Care Med; 2024 Aug 01; 210(3):318-328. PubMed ID: 38568735
    [Abstract] [Full Text] [Related]

  • 9. Risk factors and clinical characteristics for bronchopulmonary dysplasia associated pulmonary hypertension in very-low-birth-weight infants.
    Sun J, Weng B, Zhang X, Chu X, Cai C.
    BMC Cardiovasc Disord; 2021 Oct 24; 21(1):514. PubMed ID: 34689755
    [Abstract] [Full Text] [Related]

  • 10. Surgical ligation, not transcatheter closure, associated with a higher severity of bronchopulmonary dysplasia in extremely preterm infant intervened for patent ductus arteriosus.
    Wei YJ, Ju YT, Hsieh ML, Kan CD, Lin YC, Wang JN.
    Pediatr Pulmonol; 2023 Apr 24; 58(4):1221-1228. PubMed ID: 36696083
    [Abstract] [Full Text] [Related]

  • 11. [Assessment of risk factors for bronchopulmonary dysplasia with pulmonary hypertension and construction of a prediction nomogram model].
    Dai SZ, Li SS, Zhou MY, Xu Y, Zhang L, Zhang YH, Ye DN, Xu LP, Han SP.
    Zhonghua Er Ke Za Zhi; 2023 Oct 02; 61(10):902-909. PubMed ID: 37803857
    [Abstract] [Full Text] [Related]

  • 12. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.
    Mirza H, Garcia J, McKinley G, Hubbard L, Sensing W, Schneider J, Oh W, Wadhawan R.
    J Perinatol; 2019 Dec 02; 39(12):1648-1655. PubMed ID: 31554913
    [Abstract] [Full Text] [Related]

  • 13. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
    Gudmundsdottir A, Johansson S, Håkansson S, Norman M, Källen K, Bonamy AK.
    Neonatology; 2015 Dec 02; 107(2):87-92. PubMed ID: 25412681
    [Abstract] [Full Text] [Related]

  • 14. The Impact of Atrial Left-to-Right Shunt on Pulmonary Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia.
    Choi EK, Jung YH, Kim HS, Shin SH, Choi CW, Kim EK, Kim BI, Choi JH.
    Pediatr Neonatol; 2015 Oct 02; 56(5):317-23. PubMed ID: 26328892
    [Abstract] [Full Text] [Related]

  • 15. Active versus restrictive ligation strategy for patent ductus arteriosus - A retrospective two-center study of extremely preterm infants born between 22 + 0 and 25 + 6 weeks of gestational age.
    Söderström F, Sindelar R, Olsson KW, Yousef S, Todorova D, Pestalozzi J, Mellander M, Raaijmakers R.
    Early Hum Dev; 2024 Apr 02; 191():105976. PubMed ID: 38452632
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
    Liebowitz M, Clyman RI.
    J Pediatr; 2017 Aug 02; 187():119-126.e1. PubMed ID: 28396025
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Patent ductus arteriosus and the association between lung ultrasound score and bronchopulmonary dysplasia: a secondary analysis of a prospective study.
    Li Z, Mu X, Lv X, Guo Y, Si S, Wu H.
    Eur J Pediatr; 2024 Oct 02; 183(10):4309-4317. PubMed ID: 39073470
    [Abstract] [Full Text] [Related]

  • 20. Relationship between Duration of Infant Exposure to a Moderate-to-Large Patent Ductus Arteriosus Shunt and the Risk of Developing Bronchopulmonary Dysplasia or Death Before 36 Weeks.
    Clyman RI, Hills NK, Liebowitz M, Johng S.
    Am J Perinatol; 2020 Jan 02; 37(2):216-223. PubMed ID: 31600791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.